Average life expectancy across many parts of sub-Saharan Africa plummets as a result of the HIV epidemic. But after generics become available, countries start antiretroviral programmes which bring about improvements in life expectancy.
HIV funding from the USA dwarfs funding from other donor countries - although some countries contribute more when compared to their population and GDP.
